Related Experiment Video

Updated: Jun 9, 2026

Assessment of DNA Double Strand Break Repair Activity Using High-throughput and Quantitative Luminescence-Based Reporter Assays
05:01

Assessment of DNA Double Strand Break Repair Activity Using High-throughput and Quantitative Luminescence-Based Reporter Assays

Published on: June 14, 2024

Perspective on the pipeline of drugs being developed with modulation of DNA damage as a target

Ruth Plummer1

  • 1Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom. Ruth.plummer@ncl.ac.uk

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|September 9, 2010
PubMed

Insights

DNA repair inhibitors are advancing in development, offering new cancer treatment strategies. Targeting these pathways shows promise for overcoming resistance and achieving synthetic lethality, especially with poly-ADP ribose polymerase (PARP) inhibitors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Development

Background:

  • DNA repair pathways are critical for maintaining genomic stability.
  • Inhibitors targeting DNA repair are in clinical and preclinical development.
  • Initial focus was on overcoming chemo- and radiotherapy resistance.

Purpose of the Study:

  • To explore the evolving role of DNA repair inhibitors in cancer therapy.
  • To highlight the potential of synthetic lethality approaches.
  • To discuss the implications of understanding DNA repair pathway interactions for combination therapies.

Main Methods:

  • Review of current clinical and preclinical data on DNA repair inhibitors.
  • Analysis of emerging evidence for synthetic lethality.
  • Exploration of the biological interactions between DNA repair pathways.

Main Results:

  • DNA repair inhibitors are progressing through drug development pipelines.
  • Synthetic lethality has emerged as a key mechanism for single-agent efficacy, exemplified by poly-ADP ribose polymerase (PARP) inhibitors.
  • Understanding pathway crosstalk suggests potential for rational combination therapies.

Conclusions:

  • Targeting DNA repair pathways offers a promising strategy beyond overcoming resistance.
  • Synthetic lethality provides a validated approach for single-agent therapy.
  • Combinatorial strategies involving DNA repair inhibitors hold significant clinical potential.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...